3-5
2026
影响因子区间
—
平台估算
9%
2025
中国作者发文占比
2650 USD
收费
期刊简介:Expert Opinion on Biological Therapy (1471-2598; 1744-7682) is a MEDLINE-indexed, international journal publishing peer-reviewed research across all aspects of biological therapy.Each article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development.The audience consists of scientists and managers in the healthcare and biopharmaceutical industries and others closely involved in the development and application of biological therapies for the treatment of human disease.The journal welcomes:Reviews covering therapeutic antibodies and vaccines, peptides and proteins, gene therapies and gene transfer technologies, cell-based therapies and regenerative medicineDrug evaluations reviewing the clinical data on a particular biological agentOriginal research papers reporting the results of clinical investigations on biological agents and biotherapeutic-based studies with a strong link to clinical practice Comprehensive coverage in each review is complemented by the unique Expert Collection format and includes the following sections:Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results;Article Highlights – an executive summary of the author’s most critical points.
【译文】《生物治疗专家意见》(1471-2598;1744-7682)是一本MEDLINE索引的国际期刊,涵盖生物治疗的各个方面,发表同行评审的研究。每篇文章都旨在结合作者对主题对研究和临床实践的影响以及未来发展的前景的个人观点。读者包括医疗保健和生物制药行业的科学家和管理人员,以及其他与人类疾病生物治疗开发和应用密切相关的人。该期刊欢迎以下内容:涵盖治疗性抗体和疫苗、肽和蛋白质、基因治疗和基因转移技术、基于细胞的疗法和再生医学的综述;审查特定生物制剂临床数据的药物评估;报告生物制剂和基于生物治疗的临床研究结果的原创研究论文,这些研究具有与临床实践紧密的联系;每篇综述的全面覆盖都辅以独特的专家收藏格式,包括以下部分:专家意见——对文章中呈现的数据的个人观点,讨论可能对未来重要的进展,以及随着进一步研究产生更详细的结果而可能变得令人兴奋的研究途径;文章亮点——作者最关键点的执行摘要。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q2 | 暂无 |
| 影响因子区间 | 3-5 | 暂无 |